New Preclinical Model Offers Insights into Parkinson's Disease and Detecting the Disease

A new study led by Weill Cornell Medicine researchers has developed a preclinical model that allows for the study of Parkinson's disease and its effects on the brain and body. The model, which involves knocking out a key component involved in protein transportation in the light-sensing rod cells of mice, leads to the retinal accumulation of alpha-synuclein aggregates found in patients with Parkinson's disease. The researchers demonstrated that this model can be used to detect the disease in people, suggesting a relatively easy method for early detection.

Key Takeaways:

• The new preclinical model involves knocking out VPS35, a protein involved in protein transportation in rod cells, leading to the accumulation of alpha-synuclein aggregates found in Parkinson's disease patients.
• The study showed that even in young mice, the rods lacking VPS35 soon lost their synapses, resulting in visual impairment similar to that seen in patients with Parkinson's.
• Alpha-synuclein aggregates began to form, and eventually, as the affected rods began to die, the mouse retinas showed large, insoluble inclusions that looked like Lewy bodies.
• The model's advantages include a rapidly developing disease process and the absence of any artificial modification to the mice's alpha-synuclein.
• The findings suggest that the new model could be very useful for studying disease mechanisms and testing potential therapies.
• The study's authors also propose a potential new strategy for detecting Parkinson's disease using a standard ophthalmological device called a fundoscope.
• The research was supported in part by the National Eye Institute and the National Institute on Aging, both part of the National Institutes of Health.

Statistics:

• Parkinson's disease affects approximately 1 million Americans.
• The disease is diagnosed in the United States at the rate of about 90,000 new cases annually.
• Alpha-synuclein aggregates began to form in 3-month old mice lacking rod-cell VPS35.
• The researchers observed bright spots of "autofluorescence" caused by lipofuscin molecules, which associate with alpha-synuclein aggregates, using a standard ophthalmological device called a fundoscope.

Sources:

• Sung, C-H., et al. (2023, July 23). A preclinical model for Parkinson's disease. Nature Communications, 14, 1-12. (https://www.nature.com/articles/s41467-023-39185-y)